- $2.56m
- $4.14m
Annual balance sheet for NewGenIvf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | — | 0.055 | 0.042 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 0.277 | 0.092 | 0.051 |
| Long Term Investments | |||
| Total Assets | 0.277 | 70.8 | 21.3 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.254 | 0.05 | 2.24 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 0.254 | 2.46 | 5.72 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 0.023 | 68.3 | 15.6 |
| Total Liabilities & Shareholders' Equity | 0.277 | 70.8 | 21.3 |
| Total Common Shares Outstanding |